Nanostring GeoMx Annual Service Contract
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The National Institutes of Health, through the Office of Alcohol Abuse and Alcoholism, has initiated a presolicitation for an annual service contract to maintain the GeoMx Digital Spatial Profiler instrument, which was acquired to investigate tissue heterogeneity and microenvironment complexity in alcohol-induced organ injury and fibrosis models. This cutting-edge platform enables non-destructive, high-resolution profiling of RNA and protein expression across distinct tissue compartments and cell populations, integrating seamlessly with standard histology workflows to identify novel biomarkers, elucidate disease mechanisms, and evaluate drug actions in preclinical models. The instrument is critical for multiple ongoing research projects across several labs at NIAAA, supporting advanced spatial biology studies that require precise, scalable, and automated analyses. The contract, identified by solicitation number 75N98026Q00674 and NAICS code 334516, is open for response until July 2, 2026, with no set-aside requirements. It is managed by the Department of Health and Human Services, with performance and office locations in Bethesda, Maryland. Vishnuvajjala Hanumanth Rao serves as the primary point of contact, reachable via email at vishnuh@mail.nih.gov. The service contract will ensure the continued operational integrity of the GeoMx DSP system, enabling uninterrupted research into complex disease processes and facilitating the advancement of therapeutic discovery in alcohol-related and fibrotic conditions.
General Info
Agency
NAICS
Place of Performance
Bethesda, MD, 20892, USASet-Aside
Timeline
Response Deadline
Organization & Contact Information
Full Description
We purchased the GeoMx Digital Spatial Profiler (DSP) instrument to study tissue heterogeneity and the complexity of microenvironments in the spatial context related to alcohol-induced organ injury and in various fibrosis models. GeoMx DSP is the only spatial biology platform that non-destructively profiles the expression of RNA and protein from distinct tissue compartments and cell populations with an automated and scalable workflow that integrates with standard histology staining. This technique will help us discover novel biomarkers for disease severity, understand disease mechanisms and progression, uncover drug mechanisms of action, and study preclinical models. Currently, multiple labs at NIAAA plan to use this instrument for their ongoing projects.
